Tag Archives: COPD

Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment

December 26th, 2018 Editors Cardiology, Medicine Teva Pharmaceutical, based in Israel, landed the first FDA approval for a digital inhaler with built-in sensors. The ProAir Digihaler (albuterol sulfate 117 mcg) Inhalation Powder is indicated for people suffering from asthma & COPD as a way of preventing and treating bronchospasm, a tightening of the muscles that line the airways.… Read More »

Blood Eosinophilia-Targeted COPD Treatment: LABA-ICS vs LAMAs

December 06, 2018 Share this content: The incidence of pneumonia rose with initiation of LABA-ICS, which was similar across all eosinophil concentrations. Blood eosinophil concentrations could be used to target patients with chronic obstructive pulmonary disease (COPD) who are likely to respond to initial long-acting bronchodilator therapy. This, in turn, may help clinicians decide between… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »